Insurance coverage for physical ailments has expanded steadily, while coverage for mental health issues remains out of step ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

TMS has been approved for treating clinical depression in adults since 2008. Recent effectiveness data with adolescents shows ...

Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

DENVER, Dec. 16, 2024 /PRNewswire/ -- Family Care Center has published promising new research on a groundbreaking treatment for patients with anxiety and major depressive disorder (MDD).

Researchers conducted nine- and 18-month follow-ups to assess whether participants had developed a major depressive disorder, anxiety disorder, or suicidal ideation. They found that a blunted ...